Source:http://linkedlifedata.com/resource/pubmed/id/16836259
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2006-7-13
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0970-258X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
19
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
119-22
|
| pubmed:dateRevised |
2009-7-30
|
| pubmed:meshHeading |
pubmed-meshheading:16836259-Drug Utilization,
pubmed-meshheading:16836259-Fibrinolytic Agents,
pubmed-meshheading:16836259-Humans,
pubmed-meshheading:16836259-Physician's Practice Patterns,
pubmed-meshheading:16836259-Risk Assessment,
pubmed-meshheading:16836259-Stroke,
pubmed-meshheading:16836259-Thrombolytic Therapy,
pubmed-meshheading:16836259-Time Factors
|
| pubmed:articleTitle |
Thrombolysis for stroke in clinical practice: are we doing enough?
|
| pubmed:publicationType |
Editorial
|